Tag: batch variability
Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Archives
Recent-posts
Therapeutic Drug Monitoring for Generic NTIs: Protecting Patients on Antiretroviral Therapy
Feb, 26 2026

Medications